HEART PROCEDURE SUPERIOR TO DRUGS FOR COMMON ARRHYTHMIA A minimally invasive procedure that “rewires” the heart may be a ...
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and Boston Scientific Corporation (NYSE:BSX) ranks 1st on this list ...
At the Heart Rhythm Society’s 2026 meeting, Medtronic and Boston Scientific reported promising trial results for pulsed-field ablation (PFA) devices targeting dangerous heart rhythms. Medtronic’s ...
Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.
As one of the ugliest names in the technical charts, Boston Scientific (BSX) has become quite toxic for shareholders. Since ...
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — U.S. health regulators are ...
Boston Scientific faces securities fraud lawsuit alleging withheld info on declining EP market share, unsustainable growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results